Anatara Lifesciences Ltd has released a press release.
APVMA Submission Major Milestone Achieved
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Successful Completion of Target Safety Study
- Anatara Expands Executive Team
- Anatara Trial Update
- Milestone and Market Update
- Zoetis Exclusive Research Evaluation and License Option
Later from Anatara Lifesciences
- R&D Tax Refund
- Investor Update
- Zoetis Second Payment is received
- Investor Update and R&D Tax Rebate
- ANR and Zoetis to negotiate International Detach Commercial
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences